MEIP,2019-02-28 14:02:00,2.897,2.81,,-1,-0.087,-3.00311,0,0,2.92,2.84,2.81,MEIP In regards to competitive landscape frontrunners REGN Copanlisib Betalutin Others Only worry is lack of CR in trials Thoughts
MEIP,2019-02-24 13:40:00,2.897,2.81,,-1,-0.087,-3.00311,4,2,2.92,2.84,2.81,MEIP anyone heard about this combination study for Pracinostat Just surfaced 21st of feb Any clarity is good clinicaltrialsgovct2show
